United States Bipolar Disorder Therapeutics Market Report 2016

November 2016 | 118 pages | ID: U6AE211455DEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Bipolar Disorder Therapeutics

Revenue, means the sales value of Bipolar Disorder Therapeutics

This report studies sales (consumption) of Bipolar Disorder Therapeutics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Allergan
• AstraZeneca
• BMS
• Eli Lilly
• GSK
• Janssen Pharmaceuticals
• AbbVie
• Abital Pharma
• Astellas
• Convergence Pharmaceuticals
• D Pharm
• Delpor
• Gedeon Richter
• H. Lundbeck
• Intra-Cellular Therapies
• Novartis
• Noven Pharmaceuticals
• Omeros Corporation
• Otsuka
• Pfizer
• PNBDevCo
• Reviva Pharmaceuticals
• SK Biopharmaceuticals
• Sunovion Pharmaceutical.

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Bipolar Disorder Therapeutics in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Bipolar Disorder Therapeutics Market Report 2016

1 BIPOLAR DISORDER THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Bipolar Disorder Therapeutics
1.2 Classification of Bipolar Disorder Therapeutics
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Bipolar Disorder Therapeutics
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Bipolar Disorder Therapeutics (2011-2021)
  1.4.1 United States Bipolar Disorder Therapeutics Sales and Growth Rate (2011-2021)
  1.4.2 United States Bipolar Disorder Therapeutics Revenue and Growth Rate (2011-2021)

2 UNITED STATES BIPOLAR DISORDER THERAPEUTICS COMPETITION BY MANUFACTURERS

2.1 United States Bipolar Disorder Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Bipolar Disorder Therapeutics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Bipolar Disorder Therapeutics Average Price by Manufactures (2015 and 2016)
2.4 Bipolar Disorder Therapeutics Market Competitive Situation and Trends
  2.4.1 Bipolar Disorder Therapeutics Market Concentration Rate
  2.4.2 Bipolar Disorder Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES BIPOLAR DISORDER THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Bipolar Disorder Therapeutics Sales and Market Share by Type (2011-2016)
3.2 United States Bipolar Disorder Therapeutics Revenue and Market Share by Type (2011-2016)
3.3 United States Bipolar Disorder Therapeutics Price by Type (2011-2016)
3.4 United States Bipolar Disorder Therapeutics Sales Growth Rate by Type (2011-2016)

4 UNITED STATES BIPOLAR DISORDER THERAPEUTICS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Bipolar Disorder Therapeutics Sales and Market Share by Application (2011-2016)
4.2 United States Bipolar Disorder Therapeutics Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES BIPOLAR DISORDER THERAPEUTICS MANUFACTURERS PROFILES/ANALYSIS

5.1 Allergan
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Bipolar Disorder Therapeutics Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Allergan Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 AstraZeneca
  5.2.2 Bipolar Disorder Therapeutics Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 AstraZeneca Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 BMS
  5.3.2 Bipolar Disorder Therapeutics Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 BMS Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Eli Lilly
  5.4.2 Bipolar Disorder Therapeutics Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Eli Lilly Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 GSK
  5.5.2 Bipolar Disorder Therapeutics Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 GSK Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Janssen Pharmaceuticals
  5.6.2 Bipolar Disorder Therapeutics Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Janssen Pharmaceuticals Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 AbbVie
  5.7.2 Bipolar Disorder Therapeutics Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 AbbVie Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Abital Pharma
  5.8.2 Bipolar Disorder Therapeutics Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Abital Pharma Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Astellas
  5.9.2 Bipolar Disorder Therapeutics Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Astellas Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Convergence Pharmaceuticals
  5.10.2 Bipolar Disorder Therapeutics Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Convergence Pharmaceuticals Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 D Pharm
5.12 Delpor
5.13 Gedeon Richter
5.14 H. Lundbeck
5.15 Intra-Cellular Therapies
5.16 Novartis
5.17 Noven Pharmaceuticals
5.18 Omeros Corporation
5.19 Otsuka
5.20 Pfizer
5.21 PNBDevCo
5.22 Reviva Pharmaceuticals
5.23 SK Biopharmaceuticals
5.24 Sunovion Pharmaceutical.

6 BIPOLAR DISORDER THERAPEUTICS MANUFACTURING COST ANALYSIS

6.1 Bipolar Disorder Therapeutics Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Bipolar Disorder Therapeutics

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Bipolar Disorder Therapeutics Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Bipolar Disorder Therapeutics Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET FORECAST (2016-2021)

10.1 United States Bipolar Disorder Therapeutics Sales, Revenue Forecast (2016-2021)
10.2 United States Bipolar Disorder Therapeutics Sales Forecast by Type (2016-2021)
10.3 United States Bipolar Disorder Therapeutics Sales Forecast by Application (2016-2021)
10.4 Bipolar Disorder Therapeutics Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bipolar Disorder Therapeutics
Table Classification of Bipolar Disorder Therapeutics
Figure United States Sales Market Share of Bipolar Disorder Therapeutics by Type in 2015
Table Application of Bipolar Disorder Therapeutics
Figure United States Sales Market Share of Bipolar Disorder Therapeutics by Application in 2015
Figure United States Bipolar Disorder Therapeutics Sales and Growth Rate (2011-2021)
Figure United States Bipolar Disorder Therapeutics Revenue and Growth Rate (2011-2021)
Table United States Bipolar Disorder Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table United States Bipolar Disorder Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bipolar Disorder Therapeutics Sales Share by Manufacturers
Figure 2016 Bipolar Disorder Therapeutics Sales Share by Manufacturers
Table United States Bipolar Disorder Therapeutics Revenue by Manufacturers (2015 and 2016)
Table United States Bipolar Disorder Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Bipolar Disorder Therapeutics Revenue Share by Manufacturers
Table 2016 United States Bipolar Disorder Therapeutics Revenue Share by Manufacturers
Table United States Market Bipolar Disorder Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Bipolar Disorder Therapeutics Average Price of Key Manufacturers in 2015
Figure Bipolar Disorder Therapeutics Market Share of Top 3 Manufacturers
Figure Bipolar Disorder Therapeutics Market Share of Top 5 Manufacturers
Table United States Bipolar Disorder Therapeutics Sales by Type (2011-2016)
Table United States Bipolar Disorder Therapeutics Sales Share by Type (2011-2016)
Figure United States Bipolar Disorder Therapeutics Sales Market Share by Type in 2015
Table United States Bipolar Disorder Therapeutics Revenue and Market Share by Type (2011-2016)
Table United States Bipolar Disorder Therapeutics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Bipolar Disorder Therapeutics by Type (2011-2016)
Table United States Bipolar Disorder Therapeutics Price by Type (2011-2016)
Figure United States Bipolar Disorder Therapeutics Sales Growth Rate by Type (2011-2016)
Table United States Bipolar Disorder Therapeutics Sales by Application (2011-2016)
Table United States Bipolar Disorder Therapeutics Sales Market Share by Application (2011-2016)
Figure United States Bipolar Disorder Therapeutics Sales Market Share by Application in 2015
Table United States Bipolar Disorder Therapeutics Sales Growth Rate by Application (2011-2016)
Figure United States Bipolar Disorder Therapeutics Sales Growth Rate by Application (2011-2016)
Table Allergan Basic Information List
Table Allergan Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table BMS Basic Information List
Table BMS Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table BMS Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table GSK Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Janssen Pharmaceuticals Basic Information List
Table Janssen Pharmaceuticals Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Pharmaceuticals Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Abital Pharma Basic Information List
Table Abital Pharma Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abital Pharma Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Astellas Basic Information List
Table Astellas Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astellas Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Convergence Pharmaceuticals Basic Information List
Table Convergence Pharmaceuticals Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Convergence Pharmaceuticals Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table D Pharm Basic Information List
Table D Pharm Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table D Pharm Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Delpor Basic Information List
Table Delpor Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Delpor Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Gedeon Richter Basic Information List
Table Gedeon Richter Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gedeon Richter Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table H. Lundbeck Basic Information List
Table H. Lundbeck Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table H. Lundbeck Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Intra-Cellular Therapies Basic Information List
Table Intra-Cellular Therapies Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intra-Cellular Therapies Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Noven Pharmaceuticals Basic Information List
Table Noven Pharmaceuticals Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Noven Pharmaceuticals Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Omeros Corporation Basic Information List
Table Omeros Corporation Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Omeros Corporation Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Otsuka Basic Information List
Table Otsuka Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Otsuka Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table PNBDevCo Basic Information List
Table PNBDevCo Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table PNBDevCo Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Reviva Pharmaceuticals Basic Information List
Table Reviva Pharmaceuticals Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Reviva Pharmaceuticals Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table SK Biopharmaceuticals Basic Information List
Table SK Biopharmaceuticals Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table SK Biopharmaceuticals Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Sunovion Pharmaceutical. Basic Information List
Table Sunovion Pharmaceutical. Bipolar Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sunovion Pharmaceutical. Bipolar Disorder Therapeutics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bipolar Disorder Therapeutics
Figure Manufacturing Process Analysis of Bipolar Disorder Therapeutics
Figure Bipolar Disorder Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Bipolar Disorder Therapeutics Major Manufacturers in 2015
Table Major Buyers of Bipolar Disorder Therapeutics
Table Distributors/Traders List
Figure United States Bipolar Disorder Therapeutics Production and Growth Rate Forecast (2016-2021)
Figure United States Bipolar Disorder Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table United States Bipolar Disorder Therapeutics Production Forecast by Type (2016-2021)
Table United States Bipolar Disorder Therapeutics Consumption Forecast by Application (2016-2021)